Literature DB >> 1705328

Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degrees tilt.

A Fitzpatrick1, G Theodorakis, R Ahmed, T Williams, R Sutton.   

Abstract

To determine if pacing might prevent syncope in cardioinhibitory 'Malignant Vasovagal Syndrome' (also known as 'Neurally-Mediated Bradycardia/Hypotension'), a study of dual chamber pacing during head-up 60 degrees tilt was undertaken. Paired invasive tilts were performed in 10 patients who had a history of recurrent syncope, normal routine investigations including electrophysiological study and prior tilt-induced vasovagal syncope. Vasovagal reactions of identical severity were produced by prolonged 60 degrees head-up tilt on consecutive days in seven out of 10 patients. On day 2, without pacing, seven patients had tilt-induced vasovagal reactions and six became syncopal during the reaction. On day 3, with temporary DVI pacing with rate hysteresis, seven patients had tilt-induced vasovagal reactions and 1 patient was syncopal. Syncope was aborted in the other five patients. DVI pacing significantly improved cardiac index (CI) (one +/- 0.2 to 1.6 +/- 0.3 L/min/m2, P less than 0.01) and mean arterial blood pressure (MABP) (30 +/- 11 to 48 +/- 12 mmHg, P less than 0.01) during vasovagal reactions on day 3 compared with day 2. The mean period of time that patients could tolerate in the tilted position after the onset of the tilt-induced vasovagal reaction was significantly prolonged by pacing from 0.9 +/- 1.2 to 3.2 +/- 1.6 min (P less than 0.01). Dual chamber pacing may abort syncope in 85% of patients with cardioinhibitory malignant vasovagal syndrome. Pacing may prolong consciousness sufficiently during a vasovagal reaction to allow injury to be avoided.

Entities:  

Mesh:

Year:  1991        PMID: 1705328     DOI: 10.1111/j.1540-8159.1991.tb04042.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  16 in total

1.  Treatment of vasovagal syncope: pacemaker or crossing legs?

Authors:  N van Dijk; M P Harms; M Linzer; W Wieling
Journal:  Clin Auton Res       Date:  2000-12       Impact factor: 4.435

2.  Determining the optimal pacing intervention rate for vasovagal syncope.

Authors:  A S Kurbaan; A C Franzén; Z Stack; D Heaven; G Mathur; R Sutton
Journal:  J Interv Card Electrophysiol       Date:  2000-12       Impact factor: 1.900

Review 3.  Can cardiac pacing prevent neurocardiogenic syncope?

Authors:  A K Gupta; A Maheshwari; R K Thakur; C P Shah; Y Y Lokhandwala
Journal:  J Interv Card Electrophysiol       Date:  2001-12       Impact factor: 1.900

4.  Vasodepressor Syncope.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

5.  Neurally Mediated Syncope.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-08

Review 6.  Has cardiac pacing a role in vasovagal syncope?

Authors:  Richard Sutton
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 7.  Permanent cardiac pacing as primary therapy for neurocardiogenic (reflex) syncope.

Authors:  Daniel J Kosinski; Blair P Grubb; Douglas A Wolfe
Journal:  Clin Auton Res       Date:  2004-10       Impact factor: 4.435

8.  Prolonged asystole induced by head up tilt test. Report of four cases and brief review of the prognostic significance and medical management.

Authors:  D Pentousis; J P Cooper; S M Cobbe
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

9.  Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures.

Authors:  K A McLeod; N Wilson; J Hewitt; J Norrie; J B Stephenson
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 10.  Neurocardiogenic syncope: aetiology and management.

Authors:  K A Gatzoulis; P K Toutouzas
Journal:  Drugs       Date:  2001       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.